1-1 of 1
Kerstin M. Kampa, M.D.
Close
Sort by
Journal Articles

Tandutinib (MLN518), a Potent FLT3 Inhibitor, Synergizes with Cytarabine and/or Daunorubicin in a Sequence-Independent Manner.

Marcus M. Schittenhelm, MD, Kevin W. Yee, M.D., Kerstin M. Kampa, M.D., Michael C. Heinrich, M.D.
Journal: Blood
Blood (2006) 108 (11): 1374.
https://doi.org/10.1182/blood.V108.11.1374.1374
Published: 2006